NCT06039709View on ClinicalTrials.gov

Sonodynamic Therapy in Patients With Recurrent GBM

PHASE1RecruitingINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Recurrent GlioblastomaGlioblastoma MultiformeGBM
Interventions
COMBINATION_PRODUCT

5-ALA and Low-Intensity Focused Ultrasound (SDT)

5-ALA (20mg/kg orally) given \~6 hours prior to LIFU. Focused ultrasound will target a maximum of 50% of the tumor.

Trial Locations (1)

22903

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
lead

Shayan Moosa, MD

OTHER